Delphi Genetics Competitors and Similar CompaniesClear all
OXGENE's competitors and similar companies include ZIOPHARM Oncology and Aptamer Group.
 ZIOPHARM Oncology ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer. | |||
Founding Date | Founding Date 2011 | Founding Date 2005 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Private |
Tags | |||
Locations | Locations Oxford, GB HQ | Locations Boston, US HQ | Locations Heslington, GB HQ Wilmslow, GB |
Employees | Employees 264% increase | Employees 7352% increase | Employees 343% increase |
Financial | |||
Revenue (est.) | Revenue (est.) £1m (FY, 2018) | Revenue (est.) $5k (FY, 2025) | Revenue (est.) N/A |
Net income | Net income (£2.7m) (FY, 2018) | Net income ($4.2m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
ZIOPHARM Oncology
HQ
Boston, US
Employees
73
ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer.
View company
Aptamer Group
HQ
Heslington, GB
Employees
34↑ 3% increase
Aptamer Group is a company focusing on the development of nucleic acid aptamers.
View company